Wuhan Hiteck Biological Pharma News

Wuhan Hiteck Biological Pharma: Notice on obtaining a drug registration certificate for injectable roxatidine hydrochloride acetate

Jun 3 02:50

Wuhan Hiteck Biological Pharma: Announcement on pledged repurchase transactions of some shares of the controlling shareholder

May 31 05:14

Wuhan Hiteck Biological Pharma: Announcement on the cancellation of the actual controller's shares pledge

May 31 05:14

Wuhan Hiteck Biological Pharma: 300683 Haite Biotech Investor Relations Management Information 20240531

May 31 04:08

Wuhan Hiteck Biological Pharma: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 16 05:42

Wuhan Hiteck Biological Pharma: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the Company's 2023 Annual General Meeting of Shareholders

May 16 05:42

Wuhan Hiteck Biological Pharma: Announcement on participating in the 2024 Online Group Reception Day for Investors of Listed Companies under the jurisdiction of Hubei

May 9 02:42

Wuhan Hiteck Biological Pharma: Announcement on receiving government subsidies

May 7 04:58

Wuhan Hiteck Biological Pharma: China Investment Securities Co., Ltd. sponsorship summary report on the company's issuance of shares to specific targets in 2020

May 7 03:02

Wuhan Hiteck Biological Pharma: China Investment Securities Co., Ltd. inspection opinions on the company's 2023 internal control self-evaluation report

May 7 03:02

Wuhan Hiteck Biological Pharma: Special inspection opinions of SDIC Securities Co., Ltd. on the storage and use of funds raised by the company in 2023

May 7 03:02

Wuhan Hiteck Biological Pharma: China Investment Securities Co., Ltd.'s regular on-site inspection report on the company's continuous supervision work for the second half of 2023

May 7 03:02

Wuhan Hiteck Biological Pharma: SDIC Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on the Company

May 7 03:02

Wuhan Hiteck Biological Pharma: 300683 Haite Biotech Investor Relations Management Information 20240429

Apr 29 03:48

Wuhan Hiteck Biological Pharma: 300683 Haite Biotech Investor Relations Management Information 20240429

Apr 29 03:48

Wuhan Hiteck Biological Pharma: Announcement on the progress of foreign investment

Apr 29 02:37

Hyte Biotech: Announcement of Supervisory Board Resolutions

Apr 21 11:00

Haite Biotech: Articles of Association

Apr 21 11:00

Haite Biotech: 2023 Independent Director Debriefing Report (Ran Mingdong)

Apr 21 11:00

Haite Biotech: Special Audit Report on the Company's Non-Operating Capital Occupation and Other Related Capital Transactions Summary Table

Apr 21 11:00